The rollout of the Johnson & Johnson COVID-19 vaccine has been delayed in Europe.
Sweden's Health Agency has said it would pause plans to start using Johnson & Johnson's COVID-19 vaccine following reports of rare blood clots similar to those reported for the AstraZeneca shot.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
The Health Agency said on Wednesday it would not start the vaccinations and await the findings of a review by the European Medicines Agency. The vaccine has not yet been used in Sweden.
US federal health agencies have recommended pausing the use of the Johnson & Johnson vaccine after six recipients developed a rare disorder involving blood clots.
Following the news, Johnson & Johnson said it was delaying the roll out of the vaccine to Europe.
Australian Associated Press
More from World
More from World
